Trial Profile
Effects of infliximab and tocilizumab on anti-cyclic citrullinated glucose-6-phosphate peptide in patients with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2014
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 16 Dec 2014 New trial record